3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Venous Thromboembolism
7
Pulmonary Embolism
5
Venous Thrombosis
4
Neoplasms
4
Neoplasm Metastasis
2
Thrombosis
1
Sarcoma
1
Pancreatic Neoplasms
1
Multiple Myeloma
1
Mesenteric Ischemia
1
Lymphoma
1
Intracranial Thrombosis
1
Fractures, Spontaneous
1
Femoral Fractures
1
Bone Neoplasms
1
Acute Deep Vein Thrombosis
1
Interventions
Temozolomide
47
Bevacizumab
41
Radiotherapy
17
Magnetic Resonance Spectroscopy
14
Irinotecan
11
Nivolumab
8
Everolimus
7
Radiation
6
poly ICLC
5
X-Rays
5
Phantoms, Imaging
5
Carboplatin
5
pembrolizumab
4
fluorodopa F 18
4
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Erlotinib Hydrochloride
4
Carmustine
4
ribociclib
3
palbociclib
3
ivosidenib
3
antineoplaston A10
3
Vorinostat
3
Radiotherapy, Intensity-Modulated
3
Radiosurgery
3
Modafinil
3
Lomustine
3
Biopsy
3
veliparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Glioma
×
Dalteparin
×
Clear all
No trials found.